The recent label expansion of Voxzogo in the United States and Europe for use in infants with achondroplasia will likely lead to a further boost in the drug’s sales. Its other drugs, like Vimizim and ...

Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision ...

The recent label expansion of Voxzogo in the United States and Europe for use in infants with achondroplasia will likely lead ...

The new data presented at the Pediatric Endocrine Society (PES) Annual Meeting regarding the use of Voxzogo for various genetic forms of short stature is promising, indicating a potential for label ...

Presented cardiac magnetic resonance (CMR) imaging evidence consistent with clinical improvement observed in patients with ...

Meryl - who has achondroplasia which causes dwarfism - was nominated for a Scottish BAFTA for her stint on the reality show. Speaking to OK! Magazine, she revealed: "I quit my job back in December. I ...

Moving now to TransCon CNP. Our value proposition with TransCon CNP is simple. It’s to establish a treatment for patients of ...

The Harry Potter actor, 54, and his children went to St Barnabas Hospice in West Sussex, which provides palliative care to ...

Leerink Partners analyst Mani Foroohar has maintained their bullish stance on BBIO stock, giving a Buy rating on April 30. Mani ...

A special moment has been celebrated by the 7 Little Johnstons family as star Liz Johnston experienced motherhood with the birth of her daughter, Leighton, alongside boyfriend Brice Bolden.

SAR-442501 is under clinical development by Sanofi and currently in Phase I for Achondroplasia. According to GlobalData, Phase I drugs for Achondroplasia does not have sufficient historical data to ...